Acta Scientific Orthopaedics (ASOR)(ISSN: 2581-8635)

Short Communication Volume 4 Issue 4

Bone Disease Treatment Study, Major Pathways

Jin-Yu Che and Da-Yong Lu*

School of Life Sciences, Shanghai University, Shanghai, China

*Corresponding Author:Da-Yong Lu, School of Life Sciences, Shanghai University, Shanghai, China.

Received: February 22, 2021; Published: March 10, 2021;


  Bone disease treatment is very important worldwide. At present, drug development, surgery and instrument are major pathways for therapeutics. Until now, several pathways are widely used in the clinic. This editorial provides biomedical information and pathways for bone disease treatments.

Keywords: Osteoporosis; Drug Development; Folk Medicine; Technology; Pathology; Modern Technology; Acupuncture; Bone-Disease


  Bone disease diagnosis, interventions and therapeutics requires new breakthroughs [1-9]. It needs different therapeutic strategies, magic bullets and paradigms [3-12]. Different aspects of pathology, therapeutics and technology are unevenly progressed. Their developmental insights are discussed in this editorial.

Major pathways Conventional therapeutics

  Drugs, surgery and assistant therapies are usual medications for bone disease treatments [13-18]. They have a long history and widely practiced in the clinic. However, these kinds of therapies loss their momentum due to lack of long-sustained financial supports and high threshold for therapeutic translations.

Technology development

  The fastest path in future is technical adaptation and renovation [19]. It represents in different therapeutic modality and technical versatility [19-26]

  • Drug development in low cost and toxicity (computer-aid drug design and molecular assessments)
  • Digital tool in diagnosis and disease analysis
  • Surgery assistance or automation by computers (3D printers of bone tissues, joint and others)
  • Supportive techniques (movement assistance and prosthetic limbs)
  • Artificial intelligence
  • New materials (inorganic, organic and bio-materials for dead bone replacement).
Traditional chinese medicine (TCM)

  Folk medicine still has its territories in bone disease treatments [27], such as acupuncture [28], herbal plaster and medicine [29,30]. By these traditional medications, clinical orthopedic treatments will be improved without the necessity of high costs of treatments and nursery.

Major therapeutics in China [27-30]
  • Massage
  • Acupuncture
  • Herbal plaster
  • Herbal medicine


  There are many diagnostic and therapeutic options and approaches in bone study. With the rapid development of diagnostic and therapeutic versatility for bone diseases, we should expect new surprise and breakthroughs in the future.


  1. Melton J. “Hip fracture; a worldwide problem today and tomorrow”.Bone14 (1993): S1-8.
  2. Choudhary D and Alam A. “Anti-osteoporotic activity of bioactive compounds from Iris germanica targeting NK-Kappa B”. EC Pharmacology and Toxicology6.8 (2018): 665-678
  3. Lu DY and Shen Y. “Bone surgery, tissue and function repairs”. EC Orthopaedics 11.3 (2020): 1-2.
  4. Zweedijk R., et al. “Scoliosis and osteopathy”. Acta Scientific Orthopaedics 3.9 (2020): 30-43.
  5. Lu DY and Che JY. “Bone disease treatment, an editorial”. EC Orthopeadics 11.8 (2020): 143-145.
  6. Lu DY., et al. “Bone disease recovery strategies, An overview”. EC Orthopaedics10.1 (2019): 1-3.
  7. Koleva IB andYoshinov B. “Rehabilitation as an essential element in the clinical practice of orthopaedics and traumatology”. Acta Scientific Orthopaedics 3.9 (2020): 44-46.
  8. Lu DY., et al. “Osteoporosis treatments for old people”. EC Orthopeadics10.5 (2019): 278-280
  9. Che JY and Lu DY. “Bone disease treatment, future direction”. EC Pharmacology and Toxicology 9.1 (2021): 7-8.
  10. Lu DY., et al. “Nursery education in schools, significance for career”. Biomedical Research and Reviews2.2 (2019): 113.
  11. Lu DY., et al. “Patient’s care and nursery in different diseases”. Hospice and Palliative Medicine International Journal3.1 (2019): 28-30.
  12. Lu DY., et al. “Patient’s care and nursery in modern medicine”. Nursery Practice and Health Care1.1 (2019): 101.
  13. Araujo JL. “The role of the orthopedic surgeon in preventing low back pain chronification”. EC Orthopaedics9.12 (2018): 809-812
  14. Negm SH. “The possible protective role of powder cuttlefish bone, crab shell and eggshell on osteoporotic rats”. Journal of Food and Diary Science 9.10 (2018): 111-121.
  15. Mobasheri A and Shakbael M. “Osteogenic effects of resveratrol in vitro: potential for the prevention and treatment of osteoporosis”. Annals of the New York Academy of Sciences1290 (2013): 59-66.
  16. Madrv H., et al. “Scaffold-mediated gene delivery for osteochondral repair”. Pharmaceutics12 (2020): 930.
  17. Lu DY., et al. “Bone surgery with bone anatomy analysis”. EC Clinical Experimental Anatomy3.1 (2020): 1-4.
  18. Moore N and Slater GL. “Surgical technique update: Slater modification of minimally invasive brostrom reconstruction”. EC Orthopaedics 10.5 (2019): 308-314.
  19. Lu DY and Che JY. “Bone disease treatments, technical advances”. EC Orthopeadics11.10 (2020): 1-3.
  20. Lu DY., et al. “3 D print for bone replacement and design”. EC Orthopaedics (2019): 1-2.
  21. Harsini SM andOryan A. “Bone grafting and the materials for using in orthopaedics”. EC Orthopaedics 9.12 (2018): 822-833
  22. Lu DY., et al. “Bone disease treatments, math-therapeutic modality”. EC Orthopaedics 10.3 (2019): 140-143.
  23. Muthuraman A., et al. “Integration of artificial intelligence in pharmacological research with deep and machine learning process”. EC Pharmacology and Toxicology7.11 (2019): 56-61.
  24. Freedman DH. “Hunting for new drugs with AI”. Nature576 (2019): s49-s53.
  25. Lu DY and Che JY. “Communication platform for reducing foot or limb amputation”. EC Emergency Medicine and Clinical Care 4.6 (2020): 74.
  26. Borrego-Gonzalez S., et al. “Sponge-like processed D-periodic self-assembled atelocollagen supports bone formation in vivo”. Materials Science and Engineering C 120 (2021).
  27. Leung PC. “Traditional Chinese medicine in orthopaedics—problems and future direction”. Open Journal of Therapy and Rehabilitation2.1 (2014): 1-4.
  28. Che JY and Lu DY. “Acupuncture for bone disease treatment”. EC Orthopaedics12.1 (2021): 15-16.
  29. Che JYand Lu DY. “Herbal plaster for bone disease treatments”. Acta Scientific Orthopaedics4.1 (2021): 1-2.
  30. Lu DYand Lu TR. “Herbal medicine in new era”. Hospice Palliative Medicine International 3.4 (2019): 125-130.


Citation: Jin-Yu Che and Da-Yong Lu. “Bone Disease Treatment Study, Major Pathways".Acta Scientific Orthopaedics 4.4 (2021):23-25.


Acceptance rate33%
Acceptance to publication20-30 days

Indexed In

News and Events

  • Certification for Review
    Acta Scientific certifies the Editors/reviewers for their review done towards the assigned articles of the respective journals.
  • Submission Timeline for Upcoming Issue
    The last date for submission of articles for regular Issues is April 30th, 2024.
  • Publication Certificate
    Authors will be issued a "Publication Certificate" as a mark of appreciation for publishing their work.
  • Best Article of the Issue
    The Editors will elect one Best Article after each issue release. The authors of this article will be provided with a certificate of "Best Article of the Issue".
  • Welcoming Article Submission
    Acta Scientific delightfully welcomes active researchers for submission of articles towards the upcoming issue of respective journals.

Contact US